Democritus University of Thrace (DUTH)
Εγκεφαλικές αγγειακές επιπλοκές σε ασθενείς με τοποθέτηση μηχανικής υποστήριξης της αριστερής κοιλίας
Abstract
dc:descriptionStroke remains a frequent and devastating complication after LVAD implantation, despite recent advances in device technology. The aim of this study was to analyze risk factors and outcomes of stroke following implantation of 200 continuous-flow LVADs at our institution. Methods: We retrospectively analyzed patients who underwent LVAD implantation from 2011-2016. Data were available for a total of 200 patients. Results: Post LVAD stroke occurred in 13% of patients (26/200). Ischemic stroke occurred in 50% of patients (13/26) and hemorrhagic stroke in 50% (13/26). The median duration of LVAD support at the time of stroke was 257,4 days. Baseline characteristics did not differ significantly between the stroke and stroke-free cohorts. The mean INR at the time of embolic stroke was 1,86 (range 1,23-3,25) and 4,62 (range 1,4-21,4) in patients with hemorrhagic stroke (p=0.014). Mortality within 30 days of stroke was 31% (8/26). Mortality for hemorrhagic stroke was 63% (5/8) and 37% (3/8) for ischemic stroke (p=0.03). Among the 18 patients that survived stroke, 28% (5/18) received a heart transplant, 39% (7/18) are receiving ongoing LVAD support and 33% (6/18) have died from unrelated causes. Multivariate analysis showed that INR level (INR<1.6: OR 2.36, 95% CI 1.22-25.66, p=0.04, and INR>3: OR 6.71, 95% CI 1.31-48.94, p=0.02), aortic cross-clamping (OR 5.22, 95% CI 1.26-21.75, p=0.02), history of previous stroke (OR 7.33, 95% CI 1.21-56.32, p=0.03), hypertension (OR 6.15, 95% CI 1.31-33.45, p=0.03), COPD (OR 2.25, 95%CI 1.17-7.58, p=0.05), postoperative infection (OR 4.5, 95% CI 1.1-19.65, p=0.04) were significant predictors for post-LVAD stroke. A continuous Pearson’s correlation was calculated between mean arterial pressure and cerebral blood flow velocity, as an indicator of cerebral autoregulation. Our results demonstrated impaired cerebral autoregulation with continuous-flow LVADs, which may potentially increase the risk of stroke with LVAD therapy. There was a trend for less stroke occurrences in the smaller, intrapericardial 3rd generation HeartWare HVADs compared to HeartMate II, although the difference was not statistically significant (9% vs 13,5%, p=0,5). Conclusion: Stroke after LVAD implantation is a complex process with multi-factorial etiology. Its occurrence significantly increases morbidity and mortality. Despite an adverse impact on survival and quality of life, several patients who suffered stroke still received a heart transplant. Strict implementation of anticoagulation protocols, avoiding postoperative infections and controlling significant co-morbodities, such as hypertension and COPD, are likely the mainstay of preventing this devastating complication.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsiouris, Athanasios
- Τσιουρής, Αθανάσιος
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46806